Zobrazeno 1 - 10
of 195
pro vyhledávání: ''
Autor:
Fabiola Paiar, Riccardo Morganti, Emanuele Neri, Angiolo Gadducci, Michela Gabelloni, Roberto Mattioni, Francesca Orlandi, Amelia Barcellini, Sabina Giusti, Concetta Laliscia
Publikováno v:
Tumori Journal. 108:376-385
Objective: To assess prognostic factors by analyzing clinical and radiomic data of patients with locally advanced cervical cancer (LACC) treated with definitive concurrent cisplatin-based chemoradiotherapy (CCRT) using magnetic resonance imaging (MRI
Autor:
Francesca Corti, Giovanni Fucà, Filippo Pagani, Alessandra Raimondi, Rosalba Miceli, Filippo de Braud, Giovanni Randon, Paolo Manca, Chiara Cremolini, Michele Prisciandaro, Filippo Pietrantonio
Publikováno v:
Tumori Journal. 107:353-359
Background: The RECOURSE trial (Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies) demonstrated an overall survival (OS) benefit of trifluridine/tipiracil (FTD/TPI) vs placebo in refractory metastati
Autor:
Tiziana Pressiani, Enrico Aitini, Fabiola Cecchi, Gianni Sanna, Daniel V.T. Catenacci, Gerardo Rosati, Lorenza Landi, Hector Soto Parra, Francesca Spada, Yuan Tian, Stefano Tamberi, Elisa Giommoni, Carmine Pinto, Todd Hembrough, Luigi Cavanna, Shankar Sellappan, Antonia Martinetti, Alberto Marchet, Stefania Mosconi, Alberto Zaniboni, Alessandro Pellegrinelli, Rosalba Miceli, Francesca Pucci, Alessandra Raimondi, Paola Bolzoni, Sarit Schwartz, Filippo Pietrantonio, Maurizio Cantore, Salvatore Corallo, Maria Di Bartolomeo
Publikováno v:
Tumori Journal. 107:150-159
Background:No predictive markers for chemotherapy activity have been validated in gastric cancer (GC). The potential value of class III β-tubulin (TUBB3) as biomarker for prognosis and resistance to taxane-based therapy was reported.Methods:We analy
Autor:
Claudio Zamagni, A. Marino, Gianfranco Filippelli, Claudio Scavelli, Caterina Fontanella, Antonio Febbraro, Anna Maria Quaranta, Pasqualinda Ferrara, Paola Schiavone, Laura Orlando, Palma Fedele, Eufemia Stefania Lutrino, Guido Giordano, Gianluca Dima, Chiara Caliolo, Nicola Calvani, Saverio Cinieri, Mariangela Giampaglia, Daniela Rubino, Domenico Bilancia
Publikováno v:
Tumori
Background: Chemotherapy plus targeted therapy is the established treatment for human epidermal growth factor receptor 2 (HER2)–overexpressing breast cancer (BC). Limited data regarding the safety and activity of the combination of eribulin and tra
Autor:
Lonardi, S., Nasti, G., Fagnani, D., Gemma, D., Ciuffreda, L., Granetto, C., Lucchesi, S., Ballestrero, A., Biglietto, M., Proserpio, I., Bergamo, F., Proietti, E., Tonini, G., Soto Parra, H
Publikováno v:
Tumori Journal. 105:243-252
Aims: BEAWARE investigated the pattern of first-line bevacizumab early interruption in the Italian real-world setting of metastatic colorectal cancer. Methods: A total of 386 patients were followed for 15 months after first-line chemotherapy + bevaci
Autor:
Giorgio de Stefano, Arianna Lanzi, Oronzo Brunetti, Daniele Bruno, Francesca Negri, Luca Faloppi, Umberto Vespasiani Gentilucci, Flavia Pagan, Giovanni Luca Frassineti, Marianna Silletta, Mario Scartozzi, Vittorina Zagonel, Daniele Santini, Andrea Casadei Gardini, Luchino Chessa, Vincenzo Dadduzio, Giorgia Marisi, Francesco Giuseppe Foschi, Stefano Cascinu, Emiliano Tamburini, Nicola Silvestris, Gianluca Masi, Lorenzo Calvetti, Giorgio Ercolani, Caterina Vivaldi, Chiara Caparello, Alessandro Leonetti, Giuseppe Aprile, N. Farella, Emanuela Scarpi, Davide Tassinari, Jody Corbelli
Publikováno v:
Tumori Journal. 104:476-479
Introduction: Although sorafenib is the upfront standard of care for advanced hepatocellular carcinoma (HCC), molecular predictors of efficacy have not been identified yet. In the ALICE-1 study, rs2010963 of VEGF-A and VEGF-C proved to be independent
Colorectal cancer and brain metastases: An aggressive disease with a different response to treatment
Autor:
Pamela Freiha, Abir El-Ahmadie, Khalil Saleh, Lionel El-Khoury, Tony Felefly, Nadine Khalife-Saleh, Georges Chahine, Tony Ibrahim
Publikováno v:
Tumori Journal. 105:427-433
Introduction: Brain metastases (BM) are rare in colorectal cancer (CRC) and are associated with a dismal prognosis. This work aims to report the rate of BM in CRC patients treated in a single institution, along with survival and prognostic factors. M
Autor:
Fabio Calabrò, Christophe Massard, Michel Ducreux, Lukas Heukamp, Todd Hembrough, Anas Gazzah, Patrizia Trenta, Jean-Charles Soria, Diane Goéré, Cora N. Sternberg, Ludovic Lacroix, Rastislav Bahleda, Maximiliano Gelli, Julien Adam, Fabiola Cecchi, Linda Mahjoubi, Philippe Jamme
Publikováno v:
Tumori Journal. 104:NP38-NP41
Introduction: Diffuse gastric cancer is associated with poor prognosis. We report a patient with metastatic gastric linitis plastica harboring human epidermal growth factor receptor 2 ( HER2) activating mutation and HER2 amplification. Case descripti
Autor:
Gabriella Saibene, Franco Berrino, Anna Villarini, Giuliana Gargano, Alice Casagrande, Maria Gaetana Di Mauro, Patrizia Pasanisi, Elisabetta Venturelli, Eliana Roveda, Mauro Cortellini, Eleonora Bruno
Publikováno v:
Tumori Journal. 104:137-142
Purpose: Age-related non-communicable chronic diseases (ArCDs) are the leading cause of mortality. The major metabolic risk factor for their development is the metabolic syndrome (MetS), defined as a clustering of risk factors of metabolic origin suc
Autor:
Claudio Codignola, Mario Scartozzi, Fausto Meriggi, Chiara Ogliosi, Giovanni Luca Ceresoli, Alberto Zaniboni, Giordano D. Beretta, Tiziana Prochilo, Alberto Caprioli, Anna Paola Fraccon
Publikováno v:
Tumori Journal. 103:443-448
Purpose Lung cancer is one of the leading causes of cancer-related death worldwide and, although targeted therapy with tyrosine kinase inhibitors has dramatically improved the rates of response and survival in advanced EGFR-mutated adenocarcinoma, th